Biopharmaceutical companies are developing 907 biologic vaccines and drugs for more than 100 conditions, according to a Pharmaceutical Research and Manufacturers of America report. The lineup includes 134 vaccines for infectious diseases, 338 drugs for cancer, 71 for autoimmune diseases and 58 for cardiovascular diseases.

Full Story:
Drug Store News

Related Summaries